Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely

Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.
No abstract available

Keywords: clinical research / practice; complication: infectious; infectious disease; kidney transplantation / nephrology; vaccine.

Publication types

  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Kidney Transplantation* / adverse effects
  • RNA, Messenger / genetics
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine